Polytopic membrane protein folding and assembly in vitro and in vivo (Review)

Abstract

The insertion and folding of proteins in biological membranes during protein synthesis in vivo is fundamental to membrane biogenesis. At present, however, certain molecular aspects of this process can only be understood by complementary studies in vitro. We bring together in vitro and in vivo results, highlighting how the studies inform each other and increase our knowledge of the folding and assembly of polytopic membrane proteins. A notable recent advance is the high-resolution crystal structure of the protein machinery responsible for membrane protein insertion into the endoplasmic reticulum. This provides an opportunity to combine in vitro and in vivo studies at a more sophisticated level and address mechanistic aspects of polytopic protein insertion and folding. Quality control is another important aspect of membrane biogenesis, and we give an overview of the current understanding of this process, focusing on cystic fibrosis as a well-studied paradigm. Mutations in the associated membrane protein, the cystic fibrosis transmembrane conductance regulator (CFTR), can cause the quality control mechanisms to prevent the mutant protein reaching its normal site of action, the cell surface. In vitro studies of CFTR shed light on the possible origins of other clinically relevant folding mutants and highlight the potential synergy between in vitro and in vivo approaches.

• Membrane protein
• folding
• translocon
• endoplasmic reticulum
• quality control

CFTR, cystic fibrosis transmembrane conductance regulator; DGK, diacylglycerol kinase; DsbB, disulfide bond reducing protein B; E. coli, Escherichia coli; ER, endoplasmic reticulum; ERAD, endoplasmic reticulum associated degradation; LDAO, lauryldimethylamine oxide; SDS, sodium dodecylsulfate; TM, transmembrane

CFTR, cystic fibrosis transmembrane conductance regulator; DGK, diacylglycerol kinase; DsbB, disulfide bond reducing protein B; E. coli, Escherichia coli; ER, endoplasmic reticulum; ERAD, endoplasmic reticulum associated degradation; LDAO, lauryldimethylamine oxide; SDS, sodium dodecylsulfate; TM, transmembrane